Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

15 Sept 2017

Abstract excerpt

BACKGROUD: The purpose of this study was to elucidate the regulation of programmed death ligand 1 (PDL1), lactate dehydrogenase A (LDHA) and miR-34a in triple negative breast cancer (TNBC) and to explore the function and mechanism of PDL1 and LDHA as competitive endogenous RNAs (ceRNAs) in TNBC via regulation of miR-34a. METHODS: Western blotting, quantitative RT-PCR (qRT-PCR) and immunohistochemistry (IHC)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28915924
DOI: 10.1186/s13046-017-0593-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34aPMID 28915924Read ↗

MCT4 Upregulates PD-L1 Expression and Defines Novel Composite Therapeutic Targets for Triple-Negative Breast CancerSemantic proximity Read ↗

Identification of Lactate-Related Subgroups and Prognostic Model in Triple-Negative Breast CancerSemantic proximity Read ↗

A Lactate-related LncRNA Model for Predicting Prognosis, Immune Landscape and Therapeutic Response in Breast CancerSemantic proximity Read ↗

A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancerSemantic proximity Read ↗

Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancerSemantic proximity Read ↗

An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast CancerSemantic proximity Read ↗

Characterization of Lactate Metabolism Score in Breast and Thyroid Cancers to Assist Immunotherapy via Large-Scale Transcriptomic Data AnalysisSemantic proximity Read ↗

KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylationSemantic proximity Read ↗

HSP90/c-Myc Axis regulated by lncRNA LINC00461 upregulation inhibited the ubiquitination of c-Myc and promotes glucose Metabolism and proliferation through LDHA in Triple-negative Breast CancerSemantic proximity Read ↗

LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5pSemantic proximity Read ↗

The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.Semantic proximity Read ↗

Lysine lactylation (Kla) might be a novel therapeutic target for breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.